| Dr Charles Noble, MD | |
|
2116 S Park Ave, Alexandria, IN 46001-8048 | |
| (765) 298-4000 | |
| Not Available |
| Full Name | Dr Charles Noble |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 23 Years |
| Location | 2116 S Park Ave, Alexandria, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881755775 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01057626A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Health At Home Llc | Fishers, IN | Home health agency |
| Hoosier Homecare Services Llc | Anderson, IN | Home health agency |
| Community Hospital Of Anderson And Madison County | Anderson, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Physicians Of Indiana Inc | 1759416662 | 1319 |
News Archive
Two-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to a substantial, unprecedented improvement in progression-free survival (PFS) in newly diagnosed patients with advanced ovarian cancer and a BRCA1 or 2 mutation, results from the phase 3 SOLO-1 trial show.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today that it has provided support for the development of guidelines for the appropriate use of negative pressure wound therapy in the spectrum of wound healing. Unique to these guidelines are recommendations for integrating NPWT into a comprehensive plan of care that includes moist wound healing dressings and other treatment modalities.
Catheter-based renal denervation is a cost-effective strategy for resistant hypertension that may result in lower cardiovascular morbidity and mortality, a modeling prediction suggests.
An international research team led by Columbia University Medical Center successfully used mouse embryonic stem cells to replace diseased retinal cells and restore sight in a mouse model of retinitis pigmentosa. This strategy could potentially become a new treatment for retinitis pigmentosa, a leading cause of blindness that affects approximately one in 3,000 to 4,000 people, or 1.5 million people worldwide.
› Verified 5 days ago
| Entity Name | Community Physicians Of Indiana Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619105244 PECOS PAC ID: 1759416662 Enrollment ID: O20100317000717 |
News Archive
Two-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to a substantial, unprecedented improvement in progression-free survival (PFS) in newly diagnosed patients with advanced ovarian cancer and a BRCA1 or 2 mutation, results from the phase 3 SOLO-1 trial show.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today that it has provided support for the development of guidelines for the appropriate use of negative pressure wound therapy in the spectrum of wound healing. Unique to these guidelines are recommendations for integrating NPWT into a comprehensive plan of care that includes moist wound healing dressings and other treatment modalities.
Catheter-based renal denervation is a cost-effective strategy for resistant hypertension that may result in lower cardiovascular morbidity and mortality, a modeling prediction suggests.
An international research team led by Columbia University Medical Center successfully used mouse embryonic stem cells to replace diseased retinal cells and restore sight in a mouse model of retinitis pigmentosa. This strategy could potentially become a new treatment for retinitis pigmentosa, a leading cause of blindness that affects approximately one in 3,000 to 4,000 people, or 1.5 million people worldwide.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles Noble, MD 6626 E 75th St Ste 500, Indianapolis, IN 46250-2890 Ph: () - | Dr Charles Noble, MD 2116 S Park Ave, Alexandria, IN 46001-8048 Ph: (765) 298-4000 |
News Archive
Two-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to a substantial, unprecedented improvement in progression-free survival (PFS) in newly diagnosed patients with advanced ovarian cancer and a BRCA1 or 2 mutation, results from the phase 3 SOLO-1 trial show.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today that it has provided support for the development of guidelines for the appropriate use of negative pressure wound therapy in the spectrum of wound healing. Unique to these guidelines are recommendations for integrating NPWT into a comprehensive plan of care that includes moist wound healing dressings and other treatment modalities.
Catheter-based renal denervation is a cost-effective strategy for resistant hypertension that may result in lower cardiovascular morbidity and mortality, a modeling prediction suggests.
An international research team led by Columbia University Medical Center successfully used mouse embryonic stem cells to replace diseased retinal cells and restore sight in a mouse model of retinitis pigmentosa. This strategy could potentially become a new treatment for retinitis pigmentosa, a leading cause of blindness that affects approximately one in 3,000 to 4,000 people, or 1.5 million people worldwide.
› Verified 5 days ago
Stephen Henry Berghofer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 112 S Harrison St, Alexandria, IN 46001 Phone: 765-724-7627 | |
David E Haag, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2116 S Park Ave, Alexandria, IN 46001 Phone: 765-724-4455 Fax: 765-724-3386 |